 Determination prostate volume transrectal US cancer screening Part Comparison prostate-specific antigen assays radiologists high-risk group prostate cancer researchers gland volume results screening blood test prostate-specific antigen PSA total men years self-referred prostate cancer programs transrectal ultrasound US digital rectal examination patients evidence cancer significant increases mean PSA values gland volume PSA values patients cancer likely volume-adjusted percentile mean deviation patients negative biopsy results Patients PSA values volume-adjusted percentile risk prostate cancer times general screening population researchers knowledge transrectal US gland volume prostate-specific antigen assay type important objective variables future prostate cancer programs volume-adjusted percentiles cost-effective management current early detection efforts